235 related articles for article (PubMed ID: 3908727)
1. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
Sakai K; Fujimoto M; Ueda T; Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Doi S
Jpn J Antibiot; 1985 Oct; 38(10):2716-34. PubMed ID: 3908726
[TBL] [Abstract][Full Text] [Related]
3. [A double-blind comparative study on the efficacy of S6472, cefaclor, in the treatment of bacterial bronchitis].
Oshima S; Yokoyama Y; Kikuiri T; Murakami T; Nishihara H; Shimizu T; Abe M; Kurihara Y; Itoh C; Takeuchi K
Jpn J Antibiot; 1986 Oct; 39(10):2726-53. PubMed ID: 3543432
[TBL] [Abstract][Full Text] [Related]
4. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections].
Horii M; Morinaga T; Takeuchi T; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Takada S
Jpn J Antibiot; 1984 Jan; 37(1):152-75. PubMed ID: 6374193
[TBL] [Abstract][Full Text] [Related]
5. [Fundamental and clinical studies on S6472 (a new prolonged acting preparation of cefaclor) in the urological field].
Kamidono S; Fujii A; Harada M; Arakawa S; Umezu K; Kataoka N; Ishigami J; Hirooka K; Shimatani N; Matsushita M
Jpn J Antibiot; 1985 Mar; 38(3):869-904. PubMed ID: 3928939
[TBL] [Abstract][Full Text] [Related]
6. [A double blind comparative study on the efficacy of S6472, cefaclor and amoxicillin, in the treatment of bacterial pneumonia].
Shibaki H; Chimoto T; Nakabayashi T; Ishii Y; Tosaka M; Watanabe H; Onodera S; Shimizu T; Sasaki N; Ikeda Y
Jpn J Antibiot; 1986 Mar; 39(3):853-86. PubMed ID: 3525883
[TBL] [Abstract][Full Text] [Related]
7. [A double-blind comparative study of S 6472 (a long-acting cefaclor) versus a conventional cefaclor preparation in complicated urinary tract infections].
Arakawa S; Takagi S; Matsumoto O; Kamidono S; Hirooka K; Hamami G; Matsumoto H; Saito H; Umezu K; Ishigami J
Jpn J Antibiot; 1990 Nov; 43(11):1873-92. PubMed ID: 2287055
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
Yura J; Shinagawa N; Mizuno A; Watanabe S; Ando M; Sakai K; Ueda T; Morimoto K; Nakamura T; Hashimoto I
Jpn J Antibiot; 1988 Oct; 41(10):1517-37. PubMed ID: 3060626
[TBL] [Abstract][Full Text] [Related]
9. [Comparative double-blind study of cefroxadine and cephalexin in the treatment of complicated urinary tract infection].
Kamidono S; Harada M; Ishigami J; Takasaki N; Miyazaki S; Furusawa T; Mizunoe Y; Ito K; Momose S; Nakamuta S
Jpn J Antibiot; 1983 Sep; 36(9):2571-94. PubMed ID: 6361324
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
[TBL] [Abstract][Full Text] [Related]
11. [A double blind controlled study on S6472 capsules and granules in complicated urinary tract infection].
Arakawa S; Matsui T; Tanaka K; Ishigami J; Kamidono S; Ito N; Tanaka H; Hasunuma Y; Omae H; Shinozaki M
Jpn J Antibiot; 1994 Feb; 47(2):195-209. PubMed ID: 8151912
[TBL] [Abstract][Full Text] [Related]
12. [Phase I clinical studies of S6472 (sustained release preparations of cefaclor)].
Ohtomo M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
Jpn J Antibiot; 1985 Mar; 38(3):822-33. PubMed ID: 4032714
[TBL] [Abstract][Full Text] [Related]
13. [Effect of S6472 and cefaclor on bacterial flora in adult human feces].
Motohiro T; Aramaki M; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T; Nishiyama T; Kuda N
Jpn J Antibiot; 1986 Jan; 39(1):177-246. PubMed ID: 3702058
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies of S6472 in otorhinolaryngologic infections].
Baba S; Kinoshita H; Mori Y; Suzuki K; Ohyama M; Katsuta K; Furuta S; Ohno I; Noboru T; Yamamoto M
Jpn J Antibiot; 1985 Jul; 38(7):1750-60. PubMed ID: 4068219
[TBL] [Abstract][Full Text] [Related]
15. [Fundamental and clinical studies of a sustained release preparation of cefaclor in the surgical field].
Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Ito T; Tanabe M; Fukuhara A; Sakakibara O
Jpn J Antibiot; 1985 Mar; 38(3):859-68. PubMed ID: 3897613
[TBL] [Abstract][Full Text] [Related]
16. [Absorption and excretion studies of S6472 (sustained release preparations of cefaclor)].
Tateno M; Ito M; Iida M; Yasuda M; Sonoyama T; Matsuda S
Jpn J Antibiot; 1985 Mar; 38(3):834-48. PubMed ID: 4032715
[TBL] [Abstract][Full Text] [Related]
17. [Prolonged action preparation of cefaclor].
Sakamoto T; Kawai S; Doi Y; Aita K; Sonoyama T; Nishimura K; Matsuda S; Ito M; Imagawa T; Yasuda M
Jpn J Antibiot; 1985 Mar; 38(3):813-21. PubMed ID: 3897611
[TBL] [Abstract][Full Text] [Related]
18. [A parallel comparative double blind study of cefixime with cefaclor in the treatment of acute suppurative otitis media in children].
Baba S; Kinoshita H; Mori Y; Suzuki K; Shimada J; Kawamura S; Onishi S; Ueda R; Kobayashi K; Itoh Y
Jpn J Antibiot; 1987 Jan; 40(1):1-24. PubMed ID: 3295321
[TBL] [Abstract][Full Text] [Related]
19. [Fundamental and clinical studies of cefaclor in oral surgery].
Morihana K; Sakamoto H; Gotoh J; Konnai T; Uematsu M; Toyoura T; Sasaki J; Ohno K; Yoshida H; Hasegawa M
Jpn J Antibiot; 1984 Jun; 37(6):1006-22. PubMed ID: 6387212
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological and clinical studies on the long acting cefaclor (S6472)].
Fujimoto M; Sakai K; Ueda T; Doi S; Sasaki T; Morimoto Y; Sawada A; Masada A
Jpn J Antibiot; 1985 Mar; 38(3):849-57. PubMed ID: 3897612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
